Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Viridian Therapeutics, Inc.\De Transaction History
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.
- $721 Billion
- Q3 2024
A detailed history of Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. holds 633,090 shares of VRDN stock, worth $15.6 Million. This represents 2.0% of its overall portfolio holdings.
Number of Shares
633,090Holding current value
$15.6 Million% of portfolio
2.0%Shares
1 transactions
Others Institutions Holding VRDN
# of Institutions
153Shares Held
62.2MCall Options Held
133KPut Options Held
207K-
Black Rock Inc. New York, NY4.77MShares$118 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.92MShares$97 Million1.68% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$95.9 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.35MShares$82.7 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.31MShares$81.7 Million0.85% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $986M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...